RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 MRD and Clinical Response Predictors of PFS in CLL
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 55
SP 17
OP 18
DO 10.1177/1559897715570607
UL http://mdc.sagepub.com/content/14/55/17.abstract
AB In chronic lymphocytic leukemia, progression-free survival in minimal residual disease–negative patients can be best predicted using a combination of minimal residual disease and the clinical response. The combination is more accurate than clinical response alone. Assessment using only splenomegaly has no influence on progression-free survival prediction.